Skip to content

Nauwkeurigheid van partiele borstbestraling met het Cyberknife

Geometric accuracy of accelerated partial breast irradiation on the Cyberknife using standard surgical clips as a fiducial marker

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25451
Enrollment
52
Registered
2018-01-08
Start date
2018-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer Borstkanker Mamma carcinoom

Interventions

CT scan before each fraction of partial breast irradiation using the Cyberknife stereotactic radiotherapy system

Sponsors

Erasmus MC, Rotterdam, The Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Female - Age > or = 50 years - Stage pTis, pT1 or pT2 (tumor size or = 2mm for DCIS - ER positive - pN0 confirmed by sentinel node biopsy or axillary lymph node dissection - At least 3 surgical clips in the tumor bed, being large titanium or tantalum type

Exclusion criteria

Exclusion criteria: - Lympho-vascular infiltration - Extensive intraductal component - Multifocal or multicentric disease - Invasive lobular carcinoma - Distant metastasis - Neoadjuvant chemotherapy - Prior irradiation to the chest - Inability to read Dutch

Design outcomes

Primary

MeasureTime frame
geometric uncertainty of Cyberknife APBI and required PTV margin

Secondary

MeasureTime frame
- Proportion of patients where the surgical clips and superficial gold markers can successfully be used as fiducials - Dosimetric gain of PTV margin reduction - Acute toxicity

Contacts

Public ContactN. Hoekstra

Postbus 5201

n.hoekstra@erasmusmc.nl010-7040704

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)